Avacta Group Plc (LON:AVCT) insider Alastair Smith bought 35,800 shares of the company’s stock in a transaction that occurred on Tuesday, March 13th. The stock was purchased at an average price of GBX 42 ($0.58) per share, for a total transaction of £15,036 ($20,773.69).

Shares of Avacta Group Plc (AVCT) opened at GBX 40.50 ($0.56) on Wednesday. Avacta Group Plc has a 52 week low of GBX 40 ($0.55) and a 52 week high of GBX 98 ($1.35). The firm has a market cap of $27.66 and a price-to-earnings ratio of -450.00.

Separately, FinnCap reaffirmed a “corporate” rating and issued a GBX 200 ($2.76) price target on shares of Avacta Group in a research note on Wednesday, November 15th.

COPYRIGHT VIOLATION NOTICE: “Avacta Group Plc (AVCT) Insider Alastair Smith Buys 35,800 Shares” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2018/03/14/avacta-group-plc-avct-insider-alastair-smith-buys-35800-shares.html.

Avacta Group Company Profile

Avacta Group plc is a biotechnology company. Avacta’s focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies.

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.